vs
Apellis Pharmaceuticals, Inc.（APLS）与POWER SOLUTIONS INTERNATIONAL, INC.（PSIX）财务数据对比。点击上方公司名可切换其他公司
Apellis Pharmaceuticals, Inc.的季度营收约是POWER SOLUTIONS INTERNATIONAL, INC.的1.0倍（$199.9M vs $191.2M），POWER SOLUTIONS INTERNATIONAL, INC.净利率更高（8.4% vs -29.5%，领先37.9%），POWER SOLUTIONS INTERNATIONAL, INC.同比增速更快（32.5% vs -5.9%），POWER SOLUTIONS INTERNATIONAL, INC.自由现金流更多（$-7.6M vs $-14.3M），过去两年POWER SOLUTIONS INTERNATIONAL, INC.的营收复合增速更高（41.7% vs 7.7%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
阿达尼能源解决方案有限公司（前身为阿达尼输电有限公司）是一家电力输配企业，总部位于艾哈迈达巴德。截至2025年4月，公司累计输电网络总长26696回路公里，是印度规模最大的民营输电企业之一。
APLS vs PSIX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $191.2M |
| 净利润 | $-59.0M | $16.1M |
| 毛利率 | — | 21.9% |
| 营业利润率 | -25.6% | 12.7% |
| 净利率 | -29.5% | 8.4% |
| 营收同比 | -5.9% | 32.5% |
| 净利润同比 | -62.2% | -31.0% |
| 每股收益（稀释后） | $-0.40 | $0.69 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $199.9M | $191.2M | ||
| Q3 25 | $458.6M | $203.8M | ||
| Q2 25 | $178.5M | $191.9M | ||
| Q1 25 | $166.8M | $135.4M | ||
| Q4 24 | $212.5M | $144.3M | ||
| Q3 24 | $196.8M | $125.8M | ||
| Q2 24 | $199.7M | $110.6M | ||
| Q1 24 | $172.3M | $95.2M |
| Q4 25 | $-59.0M | $16.1M | ||
| Q3 25 | $215.7M | $27.6M | ||
| Q2 25 | $-42.2M | $51.2M | ||
| Q1 25 | $-92.2M | $19.1M | ||
| Q4 24 | $-36.4M | $23.3M | ||
| Q3 24 | $-57.4M | $17.3M | ||
| Q2 24 | $-37.7M | $21.5M | ||
| Q1 24 | $-66.4M | $7.1M |
| Q4 25 | — | 21.9% | ||
| Q3 25 | — | 23.9% | ||
| Q2 25 | — | 28.2% | ||
| Q1 25 | — | 29.7% | ||
| Q4 24 | — | 29.9% | ||
| Q3 24 | — | 28.9% | ||
| Q2 24 | — | 31.8% | ||
| Q1 24 | — | 27.0% |
| Q4 25 | -25.6% | 12.7% | ||
| Q3 25 | 48.7% | 13.9% | ||
| Q2 25 | -18.6% | 16.9% | ||
| Q1 25 | -50.0% | 18.2% | ||
| Q4 24 | -12.3% | 17.5% | ||
| Q3 24 | -24.0% | 16.3% | ||
| Q2 24 | -14.7% | 22.9% | ||
| Q1 24 | -36.0% | 11.2% |
| Q4 25 | -29.5% | 8.4% | ||
| Q3 25 | 47.0% | 13.5% | ||
| Q2 25 | -23.6% | 26.7% | ||
| Q1 25 | -55.3% | 14.1% | ||
| Q4 24 | -17.1% | 16.1% | ||
| Q3 24 | -29.2% | 13.8% | ||
| Q2 24 | -18.9% | 19.5% | ||
| Q1 24 | -38.5% | 7.5% |
| Q4 25 | $-0.40 | $0.69 | ||
| Q3 25 | $1.67 | $1.20 | ||
| Q2 25 | $-0.33 | $2.22 | ||
| Q1 25 | $-0.74 | $0.83 | ||
| Q4 24 | $-0.30 | $1.01 | ||
| Q3 24 | $-0.46 | $0.75 | ||
| Q2 24 | $-0.30 | $0.94 | ||
| Q1 24 | $-0.54 | $0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $41.3M |
| 总债务越低越好 | — | $96.6M |
| 股东权益账面价值 | $370.1M | $178.6M |
| 总资产 | $1.1B | $424.7M |
| 负债/权益比越低杠杆越低 | — | 0.54× |
8季度趋势，按日历期对齐
| Q4 25 | $466.2M | $41.3M | ||
| Q3 25 | $479.2M | $49.0M | ||
| Q2 25 | $370.0M | $49.5M | ||
| Q1 25 | $358.4M | $50.0M | ||
| Q4 24 | $411.3M | $55.3M | ||
| Q3 24 | $396.9M | $40.5M | ||
| Q2 24 | $360.1M | $28.8M | ||
| Q1 24 | $325.9M | $33.1M |
| Q4 25 | — | $96.6M | ||
| Q3 25 | — | $96.7M | ||
| Q2 25 | — | $1.8M | ||
| Q1 25 | — | $1.0M | ||
| Q4 24 | — | $184.0K | ||
| Q3 24 | — | $238.0K | ||
| Q2 24 | — | $292.0K | ||
| Q1 24 | $93.1M | $345.0K |
| Q4 25 | $370.1M | $178.6M | ||
| Q3 25 | $401.2M | $162.5M | ||
| Q2 25 | $156.3M | $135.7M | ||
| Q1 25 | $164.2M | $84.3M | ||
| Q4 24 | $228.5M | $65.3M | ||
| Q3 24 | $237.1M | $42.1M | ||
| Q2 24 | $264.3M | $24.8M | ||
| Q1 24 | $266.7M | $3.2M |
| Q4 25 | $1.1B | $424.7M | ||
| Q3 25 | $1.1B | $458.9M | ||
| Q2 25 | $821.4M | $437.7M | ||
| Q1 25 | $807.3M | $372.7M | ||
| Q4 24 | $885.1M | $328.2M | ||
| Q3 24 | $901.9M | $339.1M | ||
| Q2 24 | $904.5M | $307.6M | ||
| Q1 24 | $831.9M | $286.8M |
| Q4 25 | — | 0.54× | ||
| Q3 25 | — | 0.60× | ||
| Q2 25 | — | 0.01× | ||
| Q1 25 | — | 0.01× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.01× | ||
| Q2 24 | — | 0.01× | ||
| Q1 24 | 0.35× | 0.11× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $-4.6M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $-7.6M |
| 自由现金流率自由现金流/营收 | -7.1% | -4.0% |
| 资本支出强度资本支出/营收 | 0.1% | 1.6% |
| 现金转化率经营现金流/净利润 | — | -0.29× |
| 过去12个月自由现金流最近4个季度 | $45.0M | $14.1M |
8季度趋势，按日历期对齐
| Q4 25 | $-14.2M | $-4.6M | ||
| Q3 25 | $108.5M | $3.3M | ||
| Q2 25 | $4.4M | $16.7M | ||
| Q1 25 | $-53.4M | $8.8M | ||
| Q4 24 | $19.4M | $32.7M | ||
| Q3 24 | $34.1M | $12.6M | ||
| Q2 24 | $-8.3M | $1.5M | ||
| Q1 24 | $-133.0M | $15.6M |
| Q4 25 | $-14.3M | $-7.6M | ||
| Q3 25 | $108.3M | $1.7M | ||
| Q2 25 | $4.4M | $14.6M | ||
| Q1 25 | $-53.4M | $5.4M | ||
| Q4 24 | $19.3M | $30.0M | ||
| Q3 24 | — | $12.1M | ||
| Q2 24 | $-8.4M | $822.0K | ||
| Q1 24 | $-133.3M | $14.8M |
| Q4 25 | -7.1% | -4.0% | ||
| Q3 25 | 23.6% | 0.8% | ||
| Q2 25 | 2.5% | 7.6% | ||
| Q1 25 | -32.0% | 4.0% | ||
| Q4 24 | 9.1% | 20.8% | ||
| Q3 24 | — | 9.7% | ||
| Q2 24 | -4.2% | 0.7% | ||
| Q1 24 | -77.3% | 15.6% |
| Q4 25 | 0.1% | 1.6% | ||
| Q3 25 | 0.0% | 0.8% | ||
| Q2 25 | 0.0% | 1.1% | ||
| Q1 25 | 0.0% | 2.5% | ||
| Q4 24 | 0.0% | 1.8% | ||
| Q3 24 | 0.0% | 0.3% | ||
| Q2 24 | 0.0% | 0.6% | ||
| Q1 24 | 0.2% | 0.9% |
| Q4 25 | — | -0.29× | ||
| Q3 25 | 0.50× | 0.12× | ||
| Q2 25 | — | 0.33× | ||
| Q1 25 | — | 0.46× | ||
| Q4 24 | — | 1.40× | ||
| Q3 24 | — | 0.73× | ||
| Q2 24 | — | 0.07× | ||
| Q1 24 | — | 2.20× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
PSIX
| Energy End Market | $153.4M | 80% |
| Industrial End Market | $33.3M | 17% |
| Transportation End Market | $4.6M | 2% |
